Pembrolizumab as Second-Line Therapy for Advanced Urothelial CarcinomaJoaquim Bellmunt, Dean F. Bajorin, Ronald de Wit et al.|New England Journal of Medicine|2017Cited by 3.4k
Enzalutamide in Metastatic Prostate Cancer before ChemotherapyTomasz M. Beer, Bertrand Tombal, Andrew J. Armstrong et al.|New England Journal of Medicine|2014Cited by 3k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialM. Bolla, M. Piérart, Laurence Collette et al.|The Lancet|2002Cited by 1.7k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Andrew J. Armstrong, Michael J. Morris et al.|Journal of Clinical Oncology|2016Cited by 1.6k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinM. Bolla, M. Piérart, Dionisio González et al.|New England Journal of Medicine|1997Cited by 1.6k